Updates and Advances in Esophageal Squamous Cell Carcinoma (ESCC)

home / scientific-interchange-and-workshop / updates-and-advances-in-esophageal-squamous-cell-carcinoma-escc
Gregory Botta, MD, PhD

EP. 1: Dr. Botta on the Diagnosis and Treatment of ESCC

January 17th 2023

Gregory Botta, MD, PhD, discusses the diagnosis and treatment of patients with esophageal squamous cell carcinoma.

Zev A. Wainberg, professor of medicine, University of California, Los Angeles (UCLA), co-director, Gastrointestinal Oncology Program, UCLA Health

EP. 2: Dr. Wainberg on Optimal Frontline Treatment Strategies for Metastatic ESCC

January 17th 2023

Zev A. Wainberg, MD, discusses standard frontline treatment approaches for patients with metastatic esophageal squamous cell carcinoma and highlights data supporting the use of tislelizumab in combination with chemotherapy in ESCC.

Michael Jon Pishvaian, MD, PhD

EP. 3: Dr. Pishvaian on the Implications of the RATIONALE-306 Trial in ESCC

January 25th 2023

Michael Jon Pishvaian, MD, PhD, discusses the clinical implications of the phase 3 RATIONALE 306 trial and the adverse effects associated with immunotherapy in patients with advanced esophageal squamous cell carcinoma.

J. Randolph (Randy) Hecht, MD

EP. 4: Dr. Hecht on the Symptoms and Diagnosis of ESCC

January 25th 2023

J. Randolph (Randy) Hecht, MD, discusses the common symptoms of esophageal squamous cell carcinoma.

Stephen A. Strickland, MD, MSCI, director of leukemia research, Sarah Cannon Transplant & Cellular Therapy Network

EP. 5: Dr. Strickland on the Diagnosis of ESCC

January 30th 2023

Stephen A. Strickland, MD, MSCI, discusses a step-by-step approach for the diagnosis and workup of esophageal squamous cell carcinoma.

Rutika Mehta, MD, MPH

EP. 6: Dr. Mehta on Frontline and Adjuvant Treatments in ESCC

February 10th 2023

Rutika Mehta, MD, MPH, discusses which patients with esophageal squamous cell carcinoma may benefit most from the different frontline treatment options available and highlights key treatment developments with adjuvant immunotherapy plus chemotherapy.

Ronan J. Kelly, MD, MBA

EP. 7: Dr. Kelly on Trials Evaluating Frontline Immunotherapy Combinations in ESCC

February 23rd 2023

Ronan J. Kelly, MD, MBA, discusses the variety of clinical trials investigating immunotherapy with or without chemotherapy in patients with esophageal squamous cell carcinoma.

Sunnie Kim, MD

EP. 8: Dr. Kim on Tislelizumab in Advanced ESCC

February 23rd 2023

Sunnie Kim, MD, contextualizes the use of tislelizumab as a frontline treatment option in advanced esophageal squamous cell carcinoma. 

Anwaar Saeed, MD

EP. 9: Dr. Saeed on Biomarkers That Influence Treatment Decisions in ESCC

March 2nd 2023

Anwaar Saeed, MD, discusses biomarkers that signal the potential efficacy of frontline immunotherapy regimens in patients with advanced esophageal squamous cell carcinoma.